Internet Enduring Material sponsored by the Stanford University School of Medicine. Presented by the Department of Medicine at the Stanford University School of Medicine.
This presentation addresses SARS-CoV2 Antibodies in Patients on Dialysis: Surveillance Strategy.
Updates on inpatient COVID-19 patients. Discussed the study results, looking at hard to reach people including older people, people living in majority minority areas, and people living in poorer areas. Good test with sufficient sample size to achieve precise estimates and quantify differences. Demonstrated proof of principle for a minimal patient burden strategy that can be employed longitudinally. Next steps is to follow over time, seroconversion rates and risk factors, repeat over time, estimate peaks and distribution of peaks.
